Results 1 to 10 of about 194,983 (307)
Exploratory analysis of potential association between oral Haemophilus and sleep disturbances in major depressive disorder patients [PDF]
BackgroundThe current study aimed to explore the specific oral microbiota profiles in major depressive disorder (MDD) patients with sleep disturbances, and to evaluate the potential mechanisms by which oral microbiota may be implicated in MDD ...
Yachen Shi+16 more
doaj +2 more sources
Nontypeable Haemophilus influenzae is a frequent cause of noninvasive mucosal inflammatory diseases but may also cause invasive diseases, such as sepsis and meningitis, especially in children and the elderly.
Jeroen D. Langereis, Jeffrey N. Weiser
doaj +2 more sources
The genera Actinobacillus, Haemophilus, and Pasteurella exhibit extensive polyphyletic branching in phylogenetic trees and do not represent coherent clusters of species.
Sohail Naushad+5 more
doaj +2 more sources
Haemophilus influenzae and the lung (Haemophilus and the lung)
Haemophilus influenzae is present as a commensal organism in the nasopharynx of most healthy adults from where it can spread to cause both systemic and respiratory tract infection.
Paul King
doaj +2 more sources
NOD2/RICK-dependent β-defensin 2 regulation is protective for nontypeable Haemophilus influenzae-induced middle ear infection. [PDF]
Middle ear infection, otitis media (OM), is clinically important due to the high incidence in children and its impact on the development of language and motor coordination.
Lee, Yoo Jin+5 more
core +17 more sources
Background: Interleukin (IL)-6 trans-signalling (IL-6TS) is emerging as a pathogenic mechanism in chronic respiratory diseases; however, the drivers of IL-6TS in the airways and the phenotypic characteristic of patients with increased IL-6TS pathway ...
S. Winslow+18 more
semanticscholar +1 more source
Haemophilus influenzae type b (Hib) seroprevalence in France: impact of vaccination schedules
Background Haemophilus influenzae serotype b (Hib) conjugate vaccine was introduced in France in 1992 as a 3 + 1 scheme at 2, 3, and 4 months (primary vaccination) with a booster at the age of 16–18 months. The vaccination was simplified in 2013 to a 2 +
Eva Hong+6 more
doaj +1 more source
The rapid rebound of invasive meningococcal disease in France at the end of 2022
Background: Invasive meningococcal disease (IMD) cases declined upon the implementation of non-pharmaceutical measures to control the COVID-19 pandemic. A rebound in IMD cases was feared upon easing these measures.
Samy Taha+6 more
doaj +1 more source
A review of the DTaP-IPV-HB-PRP-T Hexavalent vaccine in pediatric patients
Introduction Hexaxim is a hexavalent vaccine approved as primary and booster vaccination in infants 6 weeks and older, protecting against diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B and Haemophilus influenzae type b.
Andrew Dakin+2 more
doaj +1 more source